Molecular assays for the diagnosis of minimal residual head-and-neck cancer: Methods, reliability, pitfalls, and solutions

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 3803-3816

  Van Houten, V M M ^a   Tabor, M P ^a   Van den Brekel, M W M ^a   Denkers, F ^a   Wishaupt, R G A ^a   Kummer, J A ^a   Snow, G B ^a   Brakenhoff, R H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MICROSATELLITE DNA; NUCLEIC ACID; PROTEIN P53; TUMOR MARKER;

ANALYTIC METHOD; ANTIGEN ANTIBODY COMPLEX; ASSAY; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENE MUTATION; HEAD CANCER; HETEROZYGOSITY LOSS; HUMAN; INTERMETHOD COMPARISON; MINIMAL RESIDUAL DISEASE; NECK CANCER; PRIORITY JOURNAL; RELIABILITY; SHORT SURVEY; TUMOR CELL;

DNA MUTATIONAL ANALYSIS; GENES, P53; GENETIC MARKERS; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MODELS, BIOLOGICAL; MUTATION; NUCLEIC ACID HYBRIDIZATION; POINT MUTATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033766385     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (74)

1. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor
2. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma
3. Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue
4. A genetic model for colorectal tumorigenesis
5. Molecular methods for the diagnosis of cancer
6. Nucleic acid-based methods for the detection of cancer
7. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction
8. Genetic progression model for head and neck cancer: Implications for field cancerization
9. Identification of p53 gene mutations in bladder cancers and urine samples
10. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas
11. Microsatellite alterations as clonal markers for the detection of human cancer
12. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck
13. Microsatellite alterations in serum DNA of head and neck cancer patients
14. Detection of bladder cancer recurrence by microsatellite analysis of urine
15. Minimal residual disease in head and neck cancer
16. P53 mutations in human cancers
17. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
18. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
19. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA)
20. A ligase-mediated gene detection technique
21. A rapid, reliable method for detection of known point mutations: POINT-EXACCT
22. Rapid and sensitive nonradioactive detection of mutant K-ras genes via enriched PCR amplification
23. Multiple K-ras codon-12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
24. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based 'Enriched PCR' technique
25. Restriction endonuclease-mediated selective polymerase chain reaction - A novel assay for the detection of K-ras mutations in clinical samples
26. Digital PCR
27. Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry
28. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support
29. Sequence-based analysis of the human p53 gene based on microdissection of tumor biopsy samples
30. Molecular staging of head and neck squamous carcinoma
31. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes
32. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue
33. P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 Mutations in primary tumor and matched lymph node metastases
34. P53 gene mutations in oropharyngeal carcinomas: A comparison of solitary and multiple primary tumours and lymph-node metastases
35. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases, absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
36. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients
37. P53 gene mutations are not required for early dissemination of cancer cells
38. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers
39. Labeling efficiency of oligonucleotides by T4 polynucleotide kinase depends on 5'-nucleotide
40. PCR amplification of specific alleles (PASA) is a general-method for rapidly detecting known single-base changes
41. Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase
42. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
43. Mutation and cancer: Statistical study of retinoblastoma
44. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
45. Clues to the pathogenesis of familial colorectal cancer
46. Lessons from hereditary colorectal cancer
47. Laser capture microdissection: Molecular analysis of tissue
48. Shadow bands seen when typing polymorphic dinucleotide repeats: Some causes and some cures
49. Microsatellite alterations in plasma DNA of small cell lung cancer patients
50. Molecular detection of primary bladder cancer by microsatellite analysis
51. Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma
52. Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena
53. A case of cancer in which cells similar to those in the tumors were seen in the blood after death
54. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer
55. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
56. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
57. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase polymerase chain reaction
58. Micrometastases and survival in stage II colorectal cancer
59. Illegitimate transcription: Transcription of any gene in any cell type
60. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction
61. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
62. Detection of cytokeratin 19 transcripts by reverse transcriptase polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients
63. Embryonic expression of the human 40-kd keratin - Evidence from a processed pseudogene sequence
64. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells
65. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction
66. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
67. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients
68. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy
69. Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
70. Meta-analyses of studies on bone-marrow micrometastases: An independent prognostic impact remains to be substantiated
71. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
72. Characterization of CD44v6 isoforms in head and neck squamous cell carcinoma
73. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow